---
title: "Insight Molecular Diagnostics (IMDX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IMDX.US/norm.md"
symbol: "IMDX.US"
name: "Insight Molecular Diagnostics"
parent: "https://longbridge.com/en/quote/IMDX.US.md"
datetime: "2026-03-08T06:54:44.491Z"
locales:
  - [en](https://longbridge.com/en/quote/IMDX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMDX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMDX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IMDX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMDX.US/norm.md)


# Insight Molecular Diagnostics (IMDX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3388 | -0.3042 | -0.2596 | -1.93 | -0.9839 |
| ROE | 1072.26% | -688.72% | 2595.72% | 10459.93% | -333.02% |
| Revenue | 260000.00 | 518000.00 | 2.14M | 1.49M | 115000.00 |
| Net income | -10.85M | -9.74M | -6.67M | -33.51M | -13.49M |
| Operating income | -7.67M | -7.04M | -5.84M | -5.42M | -6.38M |
| Gross margin | 53.46% | 67.57% | 62.30% | 41.52% | 62.61% |
| Net margin | -4174.62% | -1880.69% | -312.02% | -2255.11% | -11733.04% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 43.94M | 50.52M | 60.36M | 35.08M | 70.22M |
| Leverage | -4.78 | 46.01 | 5.91 | -2.86 | 7.23 |
| BVPS | -0.3213 | 0.0384 | 0.3573 | -0.7033 | 0.7261 |
| Turnover | 0.0771 | 0.0680 | 0.0585 | 0.0342 | 0.0093 |
| Cash & STI | 18.69M | 24.29M | 31.03M | 8.64M | 3.36M |
| Inv & Rec | 471000.00 | 693000.00 | 459000.00 | 410000.00 | 232000.00 |
| LT assets | 6.49M | 6.67M | 7.16M | 6.32M | 6.50M |
| Net debt | -15.56M | -20.91M | -27.55M | -4.97M | 628000.00 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -4.50M | -6.28M | -5.86M | -5.35M | -5.53M |
| Investing CF | -1.05M | -349000.00 | -307000.00 | -210000.00 | -87000.00 |
| Financing CF | -120000.00 | -114000.00 | 28.56M | 10.84M | -255000.00 |
| Free CF | -3.93M | -4.17M | -2.79M | -6.01M | -2.36M |
| OCF coverage | -384.79% | -1356.16% | -1446.42% | -1808.78% | -3196.53% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -1.05M | -349000.00 | -307000.00 | -214000.00 | -87000.00 |